Introduction
The metabolic syndrome is an important risk factor for the development of Type 2 diabetes [1] [2] [3] [4] [5] . The metabolic syndrome and its components have been observed in many settings and the influence of sex on its prevalence varies between populations in different settings [6] . In Europe, the earlier studies found the metabolic syndrome to be more prevalent in men than in women [6] [7] [8] [9] . By contrast, in the USA, the prevalence of the metabolic syndrome was found to be similar between white American men and women, whereas higher prevalence rates were found among African-American and Mexican-American women than in African-American and Mexican-American men [10] . Recent epidemiological data indicate that the prevalence of the metabolic syndrome is on the increase and this increase has been steeper in women than in men during the last decade [11] [12] . Recent studies in some European countries also indicate that the sex gap in the prevalence of the metabolic syndrome may be closing [13] [14] [15] .
The increasing prevalence of the metabolic syndrome in women is thought to be largely attributable to the steady rise in obesity in women [12] , and the prevalence of obesity is particularly high among ethnic minority women living in Europe and North America [16] [17] [18] .
Evidence also indicates that the increasing prevalence of obesity has been steeper in ethnic minority women than in their white counterparts in the last decade [16] .
In Europe, only a few studies, mainly in the UK, have assessed ethnic differences in the prevalence of the metabolic syndrome [9, 19] . Studies on sex difference in metabolic syndrome prevalence among different ethnic groups are rare in Europe. It is also unknown whether the prevalence of the metabolic syndrome and its components differ by sex in different ethnic groups in different European countries. The aim of this paper was therefore to determine whether sex differences in the prevalence of the metabolic syndrome and its components vary among different ethnic groups. We hypothesized that the prevalence of the metabolic syndrome would be higher in ethnic minority women than in men.
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Patients and methods

Study population
The SUNSET study was a cross-sectional study that aimed to assess the cardiovascular risk factors among three ethnic groups in the Netherlands: African-Surinamese, HindustaniSurinamese and white Dutch people. Details of the study methods have been published elsewhere [20] [21] . Briefly, the study was based on a sample of 35-to 60-year-olds in South 
Measurements
Ethnic groups were classified according to the self-reported ethnic origin [20] . Waist circumference was measured to the nearest centimetre at midway between the lower rib margin and the iliac crest with an ordinary tape measure. Blood pressure was measured in the morning with a validated oscillometric automated digital blood pressure device (Omron M-4; XXXXX, XXXX, Japan) by trained staff in the Academic Medical Centre. Using appropriate cuff sizes, two readings were taken on the right arm in a seated position after the subject had emptied their bladder and had been seated for at least 5 min. The mean of the two readings was used in the analyses. 
Data analysis
Baseline data were expressed as means or percentages. Sex difference in the metabolic syndrome and its components were assessed in each ethnic group by means of Poisson regression analyses with robust variance [25] . Statistical analyses were performed using Stata version 11.0 (StataCorp, College Station, TX, USA).
Results
Of the 1444 who attended the physical examination, 1413 people had complete data on the metabolic syndrome. The prevalence of alcohol consumption was lower in women than in men in all ethnic groups ( Table 1 ). The mean BMI and the prevalence of smoking were higher in African-Surinamese and Hindustani-Surinamese women than in their male counterparts.
African-Surinamese women played sports less often than African-Surinamese men.
In all ethic groups, women had a higher prevalence of central obesity, but had lower prevalence of elevated blood pressure, fasting glucose and triglyceride levels than men, although not all the differences were statistically significant. African-Surinamese women had a higher prevalence of reduced HDL cholesterol than African-Surinamese men. The magnitude of the differences varied between the ethnic groups. After adjustment for age, educational level, smoking, alcohol consumption, playing sports, the adjusted prevalence ratio of central obesity was 1.18 (95% CI 1.01-1.36) in white Dutch women compared with white Dutch men; adjusted prevalence ratio 2.29 (95% CI 1.85-2.84) in African-Surinamese women compared with Africa-Surinamese women; and adjusted prevalence ratio 1.26 (95% CI 1.09-1.45) in Hindustani women compared with Hindustani-Surinamese men, respectively (Fig. 1) .
The prevalence of the metabolic syndrome was lower in white Dutch women than in white 
Discussion
Studies on sex differences in the prevalence of the metabolic syndrome and its components among different ethnic groups are rare in Europe [9] . Our current findings indicate different sex patterns in the prevalence of the metabolic syndrome among ethnic groups.
Consistent with several earlier studies in Europe [6] [7] [8] [9] , we found a lower prevalence of the metabolic syndrome in white Dutch women than in white Dutch men. By contrast, AfricanSurinamese women had a higher prevalence of the metabolic syndrome than AfricanSurinamese men. Hindustani-Surinamese men and women had a similar prevalence of the metabolic syndrome. The comparatively high prevalence of the metabolic syndrome in African-Surinamese and the lack of difference between Hindustani men and women were largely attributable to the high prevalence of central obesity and, to a lesser extent, reduced HDL cholesterol in women. The percentage of sex differences in central obesity, for example, were 49 and 22% higher in African-Surinamese and Hindustani-Surinamese women than in their respective male counterparts, compared with 12% difference in the white Dutch group.
Despite the higher prevalence of central obesity in ethnic minority women, the prevalence of Type 2 diabetes did not vary by sex. Presumably, this might be an effect of the ethnicity/sex specific cut-points.
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© 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK The higher prevalence of the metabolic syndrome in African-Surinamese women in our current study is consistent with the finding in the USA [10, 18] . In the National Health and Nutrition Examination Survey (NHANES) study, the prevalence of the metabolic syndrome was higher in African-American women than in African-American men [10, 18] . In that study, central obesity was an important factor for the higher prevalence of the metabolic syndrome in African-American women compared with African-American men in the USA. The higher prevalence of central obesity among African-descent women may contribute to their observed high prevalence of the metabolic syndrome in both Europe and the USA.
Our current findings among Hindustani-Surinamese populations, however, contrast the observations made on South Asian populations in the UK [9] . In the study of Unwin et al.
study, South Asian men had a higher prevalence of the metabolic syndrome than South Asian women (46 vs. 38%) [9] . The explanations for the different patterns of the metabolic syndrome among the South Asian populations in the UK and the Netherlands are unclear.
However, the magnitudes of the sex differences in the prevalence of the metabolic syndrome components such as central obesity and reduced HDL cholesterol were smaller in the UK than the Netherlands, which may contribute to observed differences between the two countries.
Prevention of obesity is the main therapeutic goal in patients with the metabolic syndrome [29] . The importance of weight management in preventing progression of metabolic syndrome components has been demonstrated by the Coronary Artery Risk Development in Young Adults (CARDIA) study [30] . Weight reduction is optimally achieved with a multimodality approach, including physical activity and diet [30] . Given the beneficial effects of physical activity on weight reduction, promotion of physical activity may help to bridge the gender gap in the metabolic syndrome, particularly in ethnic minority women in whom obesity is highly prevalent but physical activity levels are low.
The main strength of our study is the use of the current International Diabetes Federation definition, which incorporates ethnicity-specific cut-off points for waist circumferences [23] [24] . Our study also has limitations, including the cross-sectional nature of the study design and lack of data on other pertinent variables such as diet. Furthermore, some of the data such as playing sports and smoking were based on self-report, which may be subject to reporting bias. Finally, bias could have resulted from a differential selective response rate [21] .
In conclusion, our findings indicate different patterns in sex differences in prevalence of the metabolic syndrome among the ethnic groups. The relatively high prevalence of central obesity in African-Surinamese women may contribute to their high prevalence of the metabolic syndrome. Strategies to improve metabolic profiles among African-Surinamese and white Dutch people need to take gender differences into account.
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